• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Fractal aggregation of dihydroquercetin after lyophilization
 
  • Details
  • Full
Options
2018
Journal Article
Title

Fractal aggregation of dihydroquercetin after lyophilization

Abstract
Purpose: Fractal geometry is a relatively young mathematical concept, which has been gradually implemented in various fields of human activity. The focus of this article lies on using this powerful tool for monitoring and forecasting the water solubility of dihydroquercetin (DHQ) and its new forms, which were obtained by lyophilization with different coformers. DHQ, also known as taxifolin, is the major flavonoid of larch wood. This compound prevents the accumulation of free radicals and is characterized by a wide range of pharmacological effects. DHQ is produced industrially and is registered in Russia as an active pharmaceutical ingredient (API). Methods: DHQ co-crystals with different coformers were generated by lyophilization. The fractal dimensions of the lyophilizates were measured by photomicrography processing with special software. The water solubility was determined according to the European Pharmacopoeia 8.0. Results: It was established that the solid phases of the DHQ lyophilizates generate specific structures that agglomerate in different fractals. A correlation was shown between the DHQ fractal dimension and its water solubility. The correlation coefficient was 0.94. The relative standard deviation was no more than 1.17%. Conclusions: This study demonstrated the ability to predict the water solubility of DHQ forms by measurement of the fractal dimensions. The fractal model can find wide application in the pharmaceutical industry as a tool for automating quality assays without substance loss.
Author(s)
Terekhov, R.
Selivanova, I.
Journal
Journal of pharmaceutical innovation  
DOI
10.1007/s12247-018-9322-4
Language
English
Fraunhofer-Institut für Zelltherapie und Immunologie IZI  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024